“Long Only” Funds? Shorting Stocks Is So 2008
Isn't A "Long Only" Hedge Fund A Mutual Fund? The news from Monday's November 11 Wall Street Journal on p C1 is that hedge funds who are shorting stocks are underperforming the market and most mutual finds. In this article, Juliet Chung points out that the new "Long Only" funds "may represent...
ViroPharma (VPHM) Up 25% on Shire Acquisition (SHPG)
Biotech Stocks Perk Up on Shire/ViroPharma Merger Sweet Spot of The Market- Mid-Caps With Sales Growth One of the core Rayno Biopharmaceutical stock picks is up 25% to $49.37 in a $4.2B deal. ViroPharma, Inc. is a rare disease drug Company whose commercial product CIN-RYZE is a leading brand...
Stealth Sell-Off in Biotech Stocks: AEGR, INCY, MDVN, REGN, PCYC Update 2 11/8
Strong Jobs Report Boosts Market--Treasuries Sell -Off with 10 Year up to 2.74% Volatile Week Finds Buyers-Technical Levels Hold 11/8/13 9:45 a Biotechnology stocks rebounded today with the IBB up 3% to $203.86. The sector hit a major downdraft yesterday but we are still well above Q3 lows...
Rayno Biopharmaceutical Update: CBST,IMGN,REGN,VPHM and Large Caps Rule
Biotech Remains Strong But Momentum Is Easing Biotechnology stocks were positive today but major ETFs mixed with the FBT ($63.82) off 1.45%. Profit taking has hit some high fliers (AEGR,INCY) and many of our portfolio stocks are off their recent highs. Small and mid-caps are being sold off...
Rayno Biopharmaceutical Portfolio Nov. 1, 2013 YTD Performance…Update 1
Updated 2/11/15 see chart below Rayno 2013 Picks Outperform Biotechnology Indices and Funds Biopharmaceutical stocks hit all time highs in 2013 with major ETFs up as follows YTD: FBT ($65) up 41%, IBB ($206) up 50%, and XBI ((%120) up 36%. The Five Star Fidelity Select Biotechnology Fund...